Categories: Technology

Wix Launches App in ChatGPT, Expanding Website Creation to one of the Worlds Leading Conversational AI Platforms

Users can now generate Wix Harmony websites directly within their ChatGPT conversations

NEW YORKWix.com Ltd. (NASDAQ: WIX), a leading global platform for creating, managing and growing a complete digital presence, today announced a collaboration with OpenAI to  launch the Wix app in ChatGPT. Built using OpenAI’s Apps SDK and powered by Wix’s Model Context Protocol (MCP), the app enables anyone to create a professional-grade Wix Harmony website directly within the ChatGPT interface.

Within ChatGPT, anyone can simply describe the website they want via text or voice and a fully functional, production-ready Wix Harmony website is generated instantly. From there, they can add relevant business capabilities, analyze performance, and implement changes, all through conversation. Existing Wix users can also connect and manage their business seamlessly within ChatGPT.

“With Wix Harmony we’ve redefined how people can build online, and now we’re extending that experience into ChatGPT,” said Shahar Talmi, GM of Developer Platform at Wix. “By adding another powerful entry point to Wix Harmony, we’re making it even easier for anyone to start, run and grow their online presence in the environments they already use every day.”

“We want to help our customers use AI to solve problems and deliver genuine impact,” said Sanj Bhayro, Managing Director EMEA Sales at OpenAI. “Wix is a great example of the kind of real-world value apps can bring into ChatGPT, helping users go from an idea to a live online presence all in one place.”  

To begin, anyone can start a ChatGPT prompt with “@Wix” and the Wix app will automatically surface within the chat.  Every website created through the Wix app runs on Wix’s enterprise-grade infrastructure, with built-in capabilities for commerce, scheduling, payments, SEO and GEO, accessibility, performance, security – and more, all  included by default. The website can then be accessed through the chat or through their Wix Business Manager.

The Wix app is now available to ChatGPT users in markets where the app directory is supported. For more information, visit the Wix App.

About Wix.com Ltd.
Wix’s vision is to simplify complex technologies and deliver the best tools for every type of user and business to create online. Powered by advanced AI and enterprise-grade infrastructure, Wix is trusted by millions of users worldwide. Founded in 2006 and strengthened by the acquisition in 2025 of Base44, the no-code application platform, Wix is continuing to build for the future of the internet. 

For more about Wix, please visit our Press Room.

Media Relations Contact:  PR@wix.com 

GlobeNews Wire

Recent Posts

FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…

15 hours ago

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…

15 hours ago

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

15 hours ago

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

17 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

18 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

18 hours ago